Abstract Background The American Cancer Society, Centers for Disease Control and
Prevention, National Cancer Institute, and North American Association of Central Cancer …

Purpose: Although stereotactic body radiotherapy (SBRT) is effective in early-stage non–
small cell lung cancer (NSCLC), approximately 10%–15% of patients will fail regionally and …

Purpose We develop a deep learning (DL) radiomics model and integrate it with circulating
tumor cell (CTC) counts as a clinically useful prognostic marker for predicting recurrence …

Introduction There have been significant changes in both diagnostic procedures and therapy
for lung cancer since the beginning of the millennium. National incidence and survival data …

Background: Lung cancer screening (LCS) with low-dose CT (LDCT) was implemented in
the United States following the National Lung Screening Trial (NLST). The real-world …

Background Non‐small cell lung cancer (NSCLC) is the first cause of cancer‐related death
among men and the second among women worldwide. It also poses an economic threat to …

Purpose Although adjuvant systemic therapy (ST) is often recommended for the treatment of
patients with high-risk, early-stage non-small cell lung carcinoma (NSCLC) after surgery …

Lung resection surgery for non-small-cell lung cancer (NSCLC) is reportedly a risk factor for
developing chronic pulmonary aspergillosis (CPA). However, limited data are available …

Objectives Lung cancer survivors have a high risk of developing a second primary lung
cancer (SPLC). While national screening guidelines have been established for initial …

Objectives Insights regarding utilization and survival of surgery and radiotherapy
(stereotactic body radiotherapy (SBRT) or conventional radiotherapy (RT)) are lacking for …